SureTrader SureTrader
Home > Boards > US OTC > Delisted >

SafeCode Drug Technologies Corp. (fka SAFC)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 12/2/2016 8:35:34 PM - Followers: 106 - Board type: Free - Posts Today: 0

SafeCode Drug Technologies Corporation





 
                                        SAFC:

There are currently 219,000,000  shares outstanding. 
The company is authorized to issue 1,000,000,000 common shares.








 
 
 
 
 
 

Voice-enabled protector for administering medicine Video link.


 

(3)   Marketable Securities

 

On November 26, 2012, the Company entered into a share exchange agreement with Biomedix Incubator, an Israeli company and a shareholder of Gefen Biomed Investments, a publicly traded Israeli company. The Company issued 1,082,851 shares to Biomedix Incubator and received in return 921,790* shares of Gefen Biomed Investments. The shares were valued at $194,913 which was the market price of the Company’s shares on the date of the exchange. The investment in Gefen is less than 4.9% of Gefen’s outstanding stock.

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9453715
327

* Gefen BioMed Investments currently trades @ 15.20 ILS or $3.87 USD per share which makes the total value of this investment $3,567,327 USD

http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=GEFEN:IT



 
 




Best regards, 
Tiffany Erickson
Transfer Agent Manager
 
Nevada Agency and Transfer Company
50 West Liberty Street, Suite 880
Reno NV 89501
 
Tel: 775-322-0626
Fax: 775-322-5623
Email: tiffany@natco.org
 
www.natco.org


Company Information

SafeCode Drug Technologies Corp. is a development stage company. On December 15, 2010, the Company entered into an Assignment agreement in relation to a a voice-enabled protector for administering medicine whereby the Company acquired all of its interests. SafeCode Drug Technology Corp. focuses to license the patent-pending technology to one or more third-party partners. The Company's voice-enabled protector for administering medicine features several components, including: a barcode that identifies the patient for whom the medication is intended; a drug name identifier; a computer readable medium containing a stored template that identifies the drug trade name, and the compound name; a processing unit capable of sending the stored voice templates to a computer, and a software application hosted on a computer system.

SafeCode Drug Technologies Corporation
6 Meever HaMiltah Street JERUSALEM 97761 Israel
Phone: +972 (050) 783-9976
Fax: +972 (050) 783-9976

 

 




Recent Press Releases

SafeCode Drug Technologies Corp. Begins Trading on the Over-the-Counter Bulletin Board

Published: November 1, 2012

JERUSALEM, November 1, 2012 /PRNewswire/ --

SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of patent-pending voice recognition technology that reduces the risks of errors during the administration of prescription medications, announced today that shares of SafeCode Drug Technologies common stock have commenced trading on the OTC Bulletin Board under the symbol "SAFC".

Trading began shortly after the company was granted eligibility status by the Depository Trust Company (DTC).

SafeCode is the developer of the world's first patent-pending voice recognition technology used to confirm prescription medications prior to their administration at home or in a medical center.  

Using SafeCode technology, prescription medications stored in specially designed locked containers can only be accessed and administered once the caregiver or patient correctly announces the name of the drug.

The technology ensures that the appropriate medication is being administered, as mistakes have accounted for thousands of deaths in recent years.  Often, nurses, doctors or patients are not careful when giving or taking medications, and many medication's packaging may look similar.  SafeCode Technology prevents medication errors, and thereby reduces the risk of severe injury or accidental death.

"We are certain that the wider investment community will recognize the commercial potential for SafeCode Drug Technologies," said Joel Klopfer , Chief Executive Officer of SafeCode Drug Technologies.  "We are excited to bring this potentially life-saving technology to market, and will keep our investors abreast of the company's development in the coming weeks and months."

About SafeCode Drug Technologies

SafeCode Drug Technologies is the developer of a patent-pending voice recognition technology that provides an essential degree of security that can effectively prevent unauthorized administration of a prescription medication.  

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of SafeCode Drug Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.  SafeCode Drug Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact:
CFO, Joel Klopfer
Joel.klopfer1@gmail.com
+972-25021321
 

SafeCode Drug Technologies Corp. Granted Eligibility Status by the Depository Trust Company

Published: October 16, 2012

JERUSALEM, October 16, 2012 /PRNewswire/ --

SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of a patent-pending voice recognition technology that reduces the risks of errors during of administration of prescription medications, announced today that the company has been granted eligibility status by the Depository Trust Company (DTC). The DTC provides banks, brokerage firms and other institutions with an efficient means of moving securities and settling trades electronically.

"SafeCode Drug Technologies has acquired the patent-pending voice recognition technology that can significantly reduce the risks of errors of administering the wrong medication," said Joel Klopfer, CEO of SafeCode Drug Technologies.  "We are excited to being able in the future to bring this potentially life-saving technology to the market."

About SafeCode Drug Technologies

SafeCode Drug Technologies is the developer of a patent-pending voice recognition technology that provides an essential degree of security that can effectively prevent unauthorized administration of a prescription medication.  

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of SafeCode Drug Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.  SafeCode Drug Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact:
Joel Klopfer
CEO
+97225021322
Joel.Klopfer1@gmail.com

SOURCE Safecode Drug Technologies Corp.





ZNTR: 5,771,233-0.0001 (09/04~09/28)
 

 

PostSubject
#12648   Long time, my friend...!!!!! Work Harder 12/02/16 08:35:34 PM
#12647   SAFC revoked: Renee 11/29/16 09:54:49 AM
#12646   It is hard to argue with your post. casualriver 11/20/16 12:31:27 PM
#12645   The crap CEO does not care its shareholders Value_Investor 09/24/16 06:18:15 PM
#12644   Lmao as you warned before yes you sure OINGO BOINGO 08/19/16 07:16:14 PM
#12643   I was able to do at one time OINGO BOINGO 08/19/16 07:06:40 PM
#12642   If we can not sell as you can chesco71_com 08/19/16 05:30:49 PM
#12641   But they will get away with it and Spike5 08/19/16 11:59:29 AM
#12640   6.2 million shares worth shit. Actually shit has OINGO BOINGO 08/18/16 11:49:29 PM
#12639   Tax Write Off :( Xzibit 08/18/16 07:13:56 PM
#12638   Shocking news today! SAFC was suspened now due Value_Investor 08/12/16 04:57:45 PM
#12637   I wish that finra ... Sec... Whomever had Spike5 08/12/16 09:54:34 AM
#12636   As alerted on July 10, 2016 SAFC SEC Renee 08/12/16 09:34:38 AM
#12635   OKAY Here is an example of someone that Xzibit 08/08/16 12:14:10 PM
#12634   But hey didn't you know we are way OINGO BOINGO 08/04/16 10:42:06 PM
#12632   Any evidence or fact at all? A pipe Value_Investor 08/04/16 12:53:05 PM
#12631   PSPW is another great stock . The company JoeMonte1 08/01/16 06:18:55 PM
#12630   If you ever invested in those so-called OTC Value_Investor 07/29/16 02:18:37 PM
#12629   Hey value investor whatever you want to invest Spike5 07/29/16 11:27:56 AM
#12628   100% Misleading Info.! SAFC, MFTH, and XHUA are Value_Investor 07/28/16 04:28:58 PM
#12626   Without filing that kind of form to protect Value_Investor 07/27/16 10:56:26 AM
#12625   A doubt, to serve the Form 15-12G or chesco71_com 07/26/16 01:00:41 PM
#12624   Yes. The only issue here is: they need Value_Investor 07/26/16 12:32:26 PM
#12623   EFLN and XHUA are sub penny crap again Spike5 07/26/16 12:31:04 PM
#12622   This company $SAFC has a great asset for chesco71_com 07/26/16 07:23:18 AM
#12621   Lol amen to that only wish I did OINGO BOINGO 07/25/16 11:43:38 PM
#12619   Shocking news! The sister stock MFTH was canceled Value_Investor 07/25/16 10:57:35 AM
#12618   Why? For bounce? You know as well as OINGO BOINGO 07/24/16 11:49:06 PM
#12617   I would buy 0.0001s as many as I Value_Investor 07/24/16 03:58:58 PM
#12616   LMAO .0001 no .0002 no high risk yes OINGO BOINGO 07/22/16 11:27:07 PM
#12615   YAW! How about 0.0001 or 0.0002? SAFC has Value_Investor 07/22/16 11:31:24 AM
#12614   I would rather pass my money has been OINGO BOINGO 07/22/16 12:25:37 AM
#12613   Yes, Sir! Someones sold 20K shares at 0.0003 Value_Investor 07/21/16 01:32:30 PM
#12612   Need some slapping action Quotestream Level 2 Safecode Drug Tech times3 07/21/16 01:29:30 PM
#12611   SAFC just needs a simple "Reinstatement" action which Value_Investor 07/20/16 11:43:19 AM
#12610   Agreed VI Xzibit 07/19/16 04:13:26 PM
#12609   Thanks, Xzibit! The CEO is too lazy and Value_Investor 07/19/16 04:12:30 PM
#12608   I reached out to Uri Tagger the inventor Xzibit 07/19/16 03:55:32 PM
#12607   Any most recent contact with the company management? Value_Investor 07/19/16 01:19:16 PM
#12606   0.559M-0.0003 x 3.245M-0.0005 now. The next ask is Value_Investor 07/18/16 12:13:16 PM
#12605   Yes. Last Friday's Slapping actions almost took out Value_Investor 07/17/16 12:59:06 PM
#12604   We need some ask slapping times3 07/17/16 11:26:17 AM
#12603   Why? Any evidence? Anyway a big Slapping action Value_Investor 07/16/16 03:00:42 PM
#12602   But the Patent can be sold by itself Value_Investor 07/15/16 01:19:35 PM
#12601   Hyper Thin asks of Level2! Only 143K-0.0009 and Value_Investor 07/15/16 10:29:00 AM
#12600   Well lets hope this one does too. I JoeMonte1 07/14/16 01:54:41 PM
#12599   Very True, that is why I said the JoeMonte1 07/14/16 01:53:58 PM
#12598   Did you notice that non-reporting peer just did Value_Investor 07/14/16 01:08:06 PM
#12597   Ideas are a dime a dozen. Don't fool Xzibit 07/14/16 01:03:12 PM
#12596   That would be a plus for us. I JoeMonte1 07/14/16 12:50:55 PM
PostSubject